DekaBank Deutsche Girozentrale’s Vaxcyte PCVX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Hold	20,000	–	–	﹤0.01%	765
2026 Q1	$1.17M	Hold	20,000	–	–	﹤0.01%	765
2025 Q4	$1.49M	Hold	20,000	–	–	﹤0.01%	809
2025 Q3	$658K	Hold	20,000	–	–	﹤0.01%	939
2025 Q2	$620K	Hold	20,000	–	–	﹤0.01%	943
2025 Q1	$1.36M	Hold	20,000	–	–	﹤0.01%	795
2024 Q4	$1.67M	Hold	20,000	–	–	﹤0.01%	780
2024 Q3	$2.23M	Hold	20,000	–	–	﹤0.01%	733
2024 Q2	$1.58M	Hold	20,000	–	–	﹤0.01%	801
2024 Q1	$1.36M	Hold	20,000	–	–	﹤0.01%	819
2023 Q4	$1.23M	Hold	20,000	–	–	﹤0.01%	866
2023 Q3	$991K	Hold	20,000	–	–	﹤0.01%	882
2023 Q2	$964K	Hold	20,000	–	–	﹤0.01%	888
2023 Q1	$722K	Hold	20,000	–	–	﹤0.01%	944
2022 Q4	$943K	Buy	20,000 +6,500	+48%	+$255K	﹤0.01%	895
2022 Q3	$328K	Hold	13,500	–	–	﹤0.01%	1122
2022 Q2	$277K	Hold	13,500	–	–	﹤0.01%	1132
2022 Q1	$325K	Buy	13,500 +1,200	+10%	+$26.2K	﹤0.01%	1134
2021 Q4	$296K	Buy	12,300 +300	+3%	+$6.98K	﹤0.01%	1195
2021 Q3	$314K	Hold	12,000	–	–	﹤0.01%	1129
2021 Q2	$269K	Hold	12,000	–	–	﹤0.01%	1166
2021 Q1	$223K	Hold	12,000	–	–	﹤0.01%	1165
2020 Q4	$334K	Buy	+12,000	New	+$446K	﹤0.01%	1107

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PCVX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Vaxcyte (PCVX) position steady in Q2 2026 at 20,000 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #765.

DekaBank Deutsche Girozentrale first reported a position in PCVX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.23M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

DekaBank Deutsche Girozentrale held 20,000 shares of Vaxcyte worth $1.14M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Vaxcyte share count unchanged in Q2 2026.
Vaxcyte made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #765 holding.
DekaBank Deutsche Girozentrale first reported a position in Vaxcyte in Q4 2020 and has held it in 23 quarters since.
DekaBank Deutsche Girozentrale's Vaxcyte position peaked at $2.23M in Q3 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.